LXRX
Lexicon Pharmaceuticals, Inc.Closed1.61−0.04 −2.42%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.61 0.00%
Open
1.65
Prev close
1.65
Day range
1.591.66
52-week range
1.102.68
Volume
2.05M0.70×
Mkt cap
716.38M
P/E ttm
—
Fwd P/E
-8.45
EPS ttm
-0.1600
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−39.93%
LXRX earnings and estimates
LXRX Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
Before the open
EPS consensus
$−0.05
range −0.06 – −0.04
EPS growth vs year ago
−32.3%
year ago −0.04
Revenue consensus
$4.14M
−70.8% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±3.2%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 BMO | −0.06 | −0.05 | −24.83% | $692.00K | −3.7% | −4.1% |
| Mar '26 | May 7, 2026 BMO | 0.00 | −0.04 | +100.00% | $21.10M | +5.0% | +52.5% |
| Dec '25 | Mar 5, 2026 BMO | −0.04 | −0.07 | +43.65% | $5.49M | +0.6% | +5.5% |
| Sep '25 | Nov 6, 2025 BMO | −0.04 | −0.07 | +39.44% | $14.18M | +3.6% | +11.6% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.05 | −0.06−0.04 | −32.3% | $4.14M | −70.8% | −0.06 +11.2% | −0.06 +11.2% | 0 / 1 |
| Next quarter Dec 2026 | −0.04 | −0.04−0.03 | +9.8% | $11.22M | +104.2% | −0.05 +23.1% | −0.05 +23.1% | 2 / 0 |
| Current year Dec 2026 | −0.17 | −0.18−0.15 | −18.8% | $37.17M | −25.4% | −0.16 −4.8% | −0.16 −4.8% | 0 / 2 |
| Next year Dec 2027 | −0.19 | −0.27−0.11 | −14.6% | $16.93M | −54.4% | −0.21 +7.6% | −0.21 +7.6% | 0 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.05 | −0.07−0.04 | 2 | 0 / 0 |
| Dec 2026 | −0.04 | −0.05−0.03 | 2 | 0 / 0 |
| Mar 2027 | −0.07 | — | 1 | 0 / 0 |
| Jun 2027 | −0.07 | — | 1 | 0 / 0 |
| Sep 2027 | −0.06 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.17 | −0.19−0.15 | 3 | 0 / 0 |
| Dec 2027 | −0.24 | −0.26−0.20 | 3 | 0 / 0 |
| Dec 2028 | −0.14 | −0.17−0.12 | 2 | 0 / 0 |
| Dec 2029 | −0.10 | −0.19−0.01 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.